News Conference News ACC 2015 DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2012 CORONARY Bypass Shows Similar Results Whether On-Pump or Off Jason Kahn March 26, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012